These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraine. Peeters M; Gunthorpe MJ; Strijbos PJ; Goldsmith P; Upton N; James MF J Pharmacol Exp Ther; 2007 May; 321(2):564-72. PubMed ID: 17267580 [TBL] [Abstract][Full Text] [Related]
5. Ketamine and other glutamate receptor modulators for depression in adults. Caddy C; Amit BH; McCloud TL; Rendell JM; Furukawa TA; McShane R; Hawton K; Cipriani A Cochrane Database Syst Rev; 2015 Sep; (9):CD011612. PubMed ID: 26395901 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of memantine. Johnson JW; Kotermanski SE Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266 [TBL] [Abstract][Full Text] [Related]
7. Memantine Improves Recovery After Spreading Depolarization in Brain Slices and can be Considered for Future Clinical Trials. Reinhart KM; Humphrey A; Brennan KC; Carlson AP; Shuttleworth CW Neurocrit Care; 2021 Oct; 35(Suppl 2):135-145. PubMed ID: 34657268 [TBL] [Abstract][Full Text] [Related]
8. Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review. Fluyau D; Revadigar N; Pierre CG Drug Alcohol Depend; 2020 Mar; 208():107845. PubMed ID: 31978670 [TBL] [Abstract][Full Text] [Related]
9. Role of memantine in the prophylactic treatment of episodic migraine: A systematic review. Mistry VM; Morizio PL; Pepin MJ; Bryan WE; Brown JN Headache; 2021 Sep; 61(8):1207-1213. PubMed ID: 34352118 [TBL] [Abstract][Full Text] [Related]
10. The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Maeng S; Zarate CA Curr Psychiatry Rep; 2007 Dec; 9(6):467-74. PubMed ID: 18221626 [TBL] [Abstract][Full Text] [Related]
11. Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization. Glasgow NG; Povysheva NV; Azofeifa AM; Johnson JW J Neurosci; 2017 Oct; 37(40):9686-9704. PubMed ID: 28877967 [TBL] [Abstract][Full Text] [Related]
12. Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects. Lepow L; Luckenbaugh DA; Park L; Henter ID; Zarate CA J Psychiatr Res; 2017 Mar; 86():55-57. PubMed ID: 27914292 [No Abstract] [Full Text] [Related]
13. mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats. Sabino V; Narayan AR; Zeric T; Steardo L; Cottone P Behav Brain Res; 2013 Jun; 247():9-16. PubMed ID: 23466691 [TBL] [Abstract][Full Text] [Related]
14. Recent insights into the mode of action of memantine and ketamine. Johnson JW; Glasgow NG; Povysheva NV Curr Opin Pharmacol; 2015 Feb; 20():54-63. PubMed ID: 25462293 [TBL] [Abstract][Full Text] [Related]
15. Memantine binding to a superficial site on NMDA receptors contributes to partial trapping. Kotermanski SE; Wood JT; Johnson JW J Physiol; 2009 Oct; 587(Pt 19):4589-604. PubMed ID: 19687120 [TBL] [Abstract][Full Text] [Related]
16. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism. Lipton SA Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913 [TBL] [Abstract][Full Text] [Related]
17. Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis. de Bartolomeis A; Sarappa C; Buonaguro EF; Marmo F; Eramo A; Tomasetti C; Iasevoli F Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():1-12. PubMed ID: 23800465 [TBL] [Abstract][Full Text] [Related]
18. Comparison of behavioral effects of the NMDA receptor channel blockers memantine and ketamine in rats. Kotermanski SE; Johnson JW; Thiels E Pharmacol Biochem Behav; 2013 Aug; 109():67-76. PubMed ID: 23665480 [TBL] [Abstract][Full Text] [Related]
19. Interaction of memantine and ketamine in morphine- and pentazocine-induced antinociception in mice. Malec D; Mandryk M; Fidecka S Pharmacol Rep; 2008; 60(2):149-55. PubMed ID: 18443375 [TBL] [Abstract][Full Text] [Related]
20. Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study. Noruzzadeh R; Modabbernia A; Aghamollaii V; Ghaffarpour M; Harirchian MH; Salahi S; Nikbakht N; Noruzi N; Tafakhori A Headache; 2016 Jan; 56(1):95-103. PubMed ID: 26638119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]